ArticleFrontiers in public health2025
Mapping the global burden of early-onset Parkinson's disease: socioeconomic and regional inequalities from the Global Burden of Disease Study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A gut microbiota-based predictive model for the treatment efficacy of Parkinson's disease.Frontiers in neurology · 2025Article
- Spatiotemporal patterns and future trends of global ischemic stroke burden.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Backgrounds: Early-onset Parkinson's disease (EOPD) presents a significant financial burden on healthcare systems and medical expenses. However, there has been a lack of comprehensive quantitative assessments to fully understand the extent of this burden. The Global Burden of Diseases (GBD) initiative aims to provide a standardized and thorough evaluation of these factors on a global, regional, and national scale. This study aimed to calculate the global burden of EOPD and characterize regional disparities, SDI-based inequalities, and gender differences in disease burden, with a focus on trends from 1990 to 2021. Methods: We utilized data from the GBD Study 2021 to analyze the burden of EOPD by examining factors such as incidence, prevalence, disability-adjusted life years (DALYs), and mortality rates. We focused on trends in EOPD incidence, prevalence, DALYs, and deaths from 1990 to 2021. Additionally, socio-demographic index (SDI)-related determinants that influence EOPD DALYs and characterized the disparities in EOPD burden associated with different SDI levels over the same period. Results: In EOPD, a significant increase in age-standardized rates for incidence, prevalence, and DALYs while the death rate declined. Males exhibited a higher burden than females across all metrics. Geographic disparities showed that East Asia had the highest rates of incidence and DALYs, while Andean Latin America recorded the highest prevalence. Countries with higher SDI levels, particularly China, Bolivia, and Peru, bore the greatest burden. Socioeconomic patterns suggested high-middle SDI regions experienced the highest rates of incidence and prevalence, whereas middle-SDI regions showed the highest rates of disability and mortality. Decomposition analysis revealed population growth was the primary driver of increased DALYs in middle-SDI regions. Additionally, inequality analysis indicated that countries with higher SDI levels faced a disproportionately lower burden of disease. Conclusion: This study confirms a global increase in the burden of EOPD, and indicate rising incidence and prevalence rates, an increase in DALYs, and a decline in mortality rates. A notable predominance of male cases, along with significant geographic and socioeconomic disparities. Regions with a middle SDI experience the most significant burden of disability and mortality, primarily driven by population growth. This underscores the urgent need for targeted interventions to address these inequities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.